Inventiva S.A. (IVA)
NASDAQ·Healthcare·Biotechnology
$3.75
+3.31%
Mkt Cap $331.65M
Analyst Ratings
No recent rating data.
Price Target (7 analysts)
$15.33
Range $12.00 – $24.00
Implied Upside
+308.8%
Consensus $15.33 vs current $3.75
NASDAQ·Healthcare·Biotechnology
$3.75
+3.31%
Mkt Cap $331.65M
No recent rating data.
Price Target (7 analysts)
$15.33
Range $12.00 – $24.00
+308.8%
Consensus $15.33 vs current $3.75